Trial intelligence / Profile preview

PCC vs FFP for Post-CPB Bleeding

NCT02557672Phase 4Completed

Sponsor
Mayo Clinic
Start
Aug 2016
Primary completion
Jun 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of coagulation factor X human in coagulopathy, sponsored by Mayo Clinic. Started Aug 2016; status: completed.

02

Drugs

coagulation factor X human
03

Conditions

coagulopathy

Beyond the preview

Go deeper on NCT02557672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02557672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call